Genistein inhibited endocytosis and fibrogenesis in keloid via CTGF signaling pathways

Chun-Te Lu1,2, Jiunn-Liang Ko3,4, Chu-Chyn Ou5,6

  • 1Division of Plastic and Reconstructive Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, 407, Taiwan.

Genes & Nutrition
|October 28, 2024
PubMed
Abstract

Insights

Genistein, a soy isoflavone, effectively inhibits keloid fibroblast cell migration and proliferation by inducing cell cycle arrest via the CTGF pathway. This research offers a novel therapeutic strategy for keloid treatment.

Area of Science:

  • Biochemistry
  • Dermatology
  • Cell Biology

Background:

  • Keloids are abnormal scars resulting from excessive fibroblast activity.
  • Soy isoflavones, particularly genistein, are investigated for their therapeutic potential.
  • Human keloid fibroblast cells (KFs) and tissue models are used to study keloid pathogenesis.

Purpose of the Study:

  • To evaluate the effects of genistein on keloid fibroblast cells and tissue.
  • To investigate genistein's mechanism of action in keloid treatment.
  • To explore genistein as a potential therapeutic agent for keloids.

Main Methods:

  • Cell migration assays (wound-healing) were performed.
  • Apoptosis was measured using flow cytometry.
  • Protein and mRNA expression (COL1A1, FN, CTGF, p53) were analyzed via Western blotting and immunofluorescence.
  • Connective tissue growth factor (CTGF) knockdown was utilized.

Main Results:

  • Genistein suppressed KF proliferation and migration, inducing G2/M cell cycle arrest and upregulating p53.
  • Genistein inhibited COL1A1, FN, and CTGF expression.
  • CTGF knockdown reduced KF migration.
  • Genistein mitigated TGF-β1-induced fibrosis and reduced cell migration in a time- and dose-dependent manner.

Conclusions:

  • Genistein-induced p53 triggers cell cycle arrest through the CTGF pathway, inhibiting keloid cell proliferation.
  • Genistein effectively suppresses keloid cell migration.
  • This study presents genistein as a promising therapeutic strategy for keloid treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K